Center for Emergency Medicine maribor
Maribor, 2000, Slovenia
NCT Number: NCT01235182
Acute heart failure is one of the main causes of acute respiratory distres in prehospital emergency setting. The early and correct diagnosis is important because the misdiagnosis can result in deleterious consequeance to patients. Rapid bedside tests (like NT-proBNP) and point-of-care lung ultrasound could be useful methods in field. This study confirmed that the combination of ultrasound sign in combination with rapid NT-proBNP test has a hibh diagnostic accuracy in differentiating between cardiac and pulmonray causes of acute dyspnea in the field and the tretament possibilities in clinical obscure cases are mainly improved.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Maribor, 2000, Slovenia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Medical Centre Maribor
Other
Combination of Lung Ultrasound(a Comet-tail Sign) and N-terminal Pro-brain Natriuretic Paptide in Differentiating Acute Dyspnea in Prehospital Emergency Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03672994
Asthma, Breathlessness
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT03203759
Anticoagulants; Increased, Asthma
Boston, Massachusetts, United States
View Trial DetailsNCT00878475
Asthma, Bronchial Diseases
Maribor, Slovenia
View Trial DetailsNCT03524222
Anticoagulants; Increased, Asthma
Boston, Massachusetts, United States
View Trial Details